The Massive Spreads and Fatalities of COVID-19 Pandemic in The USA Symptoms of Leadership Failure
The Massive Spreads and Fatalities of COVID-19 Pandemic in The USA Symptoms of Leadership Failure
https://www.emerald.com/insight/2056-4929.htm
IJPL
18,2 The massive spreads and fatalities
of COVID-19 pandemic in the USA:
symptoms of leadership failure
134 Oluwole Owoye
Social Sciences, School of Arts and Sciences, Western Connecticut State University,
Received 19 August 2021
Revised 12 October 2021
Danbury, Connecticut, USA, and
16 November 2021
Accepted 18 November 2021
Olugbenga A. Onafowora
Economics, Susquehanna University, Selinsgrove, Pennsylvania, USA
Abstract
Purpose – The purpose of this paper is to empirically examine whether the massive spreads and fatalities of
the COVID-19 pandemic in the USA, the country with the most advanced medical technology in the world, are
symptomatic of leadership failure. The authors posit that when political leaders, such as the President of the
USA, in conjunction with a group of state governors and city mayors, employed conspiracy theories and
disinformation to achieve their political goals, they contributed to the massive spreads and fatalities of the
virus, and they also undermined the credibility of the Centers for Disease Control and Prevention (CDC) and the
health-care professionals in providing the pertinent control guidelines and true scientific-based medical
information.
Design/methodology/approach – The authors conducted a review of current studies that address the
handling of global infectious diseases to build a better understanding of the issue of pandemics. They then
employed a theoretical framework to link the massive spreads and fatalities of the COVID-19 pandemic to
political leaders, such as President Trump and the group of obsequious state governors and city mayors, who
propagated conspiracy theories and disinformation through social media platforms to downplay the severity of
the virus. The authors compared the massive spreads and fatalities of the COVID-19 pandemic in the USA
under President Trump to President Obama who handled H1N1, Ebola, Zika and Dengue. More importantly,
the authors compared President Trump’s handling of the COVID-19 pandemic to other political leaders in
advanced countries where there were no concerted efforts to spread conspiracy theories and disinformation
about the health risks of COVID-19 pandemic.
Findings – The authors’ theoretical analysis alluded to the fact that political leaders, such as President Trump,
who are engulfed in self-deceptions, self-projections and self-aggrandizements would engage in self-promotion
and avoid accountability for their missteps in handling global pandemic shocks. In contrast, political leaders in
other advanced countries did not downplay the severity thus their ability to curtail the spreads and fatalities of
the COVID-19 pandemic.
Research limitations/implications – The theoretical viewpoints presented in this paper along with the
derivations of the spreads–fatalities curtailment coefficients and the spread–fatality upsurge coefficients under
Presidents Obama and Trump, respectively, may not be replicable. Given this plausible limitation, future
research may need to provide a deep analysis of the amplifications of conspiracy theories and disinformation
because they are now deeply rooted in the political economy of the USA. Furthermore, since scientists and
medical professionals may not be able to forecast future epidemics or pandemics with pin-point accuracy nor
predict how political leaders would disseminate health risks information associated with different pathogens, it
is imperative that future research addresses the positive or adverse effects of conspiracy theories and
disinformation that are now easily propagated simultaneously through different social media platforms, which
are currently protected under Section 230 of the Communications Decency Act. The multiplier effects of
conspiracy theories and disinformation will continue to amplify the division about the authenticity of COVID-
19 pandemic and the emergence or reemergence of other pathogens in the foreseeable future.
Originality/value – The authors derived the unique spreads-fatalities curtailment coefficients to demonstrate
how President Obama used effective collaboration and coordination at all levels of government in conjunction
with medical experts to curtail the spreads and fatalities associated with H1N1, Ebola, Zika and Dengue. They
International Journal of Public
Leadership
Vol. 18 No. 2, 2022
pp. 134-150 The authors gratefully acknowledge the anonymous reviewers and the editors for their useful comments
© Emerald Publishing Limited and suggestions, which contributed to improving the quality of this paper. The authors are responsible
2056-4929
DOI 10.1108/IJPL-08-2021-0048 for the errors and omissions of this paper.
further derived the spreads-fatalities upsurge coefficients to highlight how President Trump contributed to the The COVID-19
spreads and fatalities of COVID-19 pandemic through his inability to collaborate and coordinate with state
governors, city mayors and different health-care agencies at the national and international levels. pandemic in
Keywords Coronavirus, Leadership, Obama, Trump, Conspiracy theories, Disinformation the USA
Paper type Research paper
Introduction 135
The outbreaks of global infectious diseases, such as the current COVID-19 pandemic, dated
back to the bubonic plague, which originated in China in 1334. The establishment of the
World Health Organization (WHO) on April 7, 1948 shortly after Second World War made
the WHO the world body designed to ensure collaboration and coordination within the
global health-care systems required to provide the necessary bulwark against anticipated
and unanticipated infectious diseases threats. According Bloom and Cadarette (2019),
during the 1948–2000 period, the world experienced prominent outbreaks of epidemics and
pandemics, such as the 1957–1958 Asian flu associated with one to two million deaths; the
1968–1969 Hong Kong flu, which resulted in 500,000 to two million deaths; the human
immunodeficiency virus-acquired immunodeficiency syndrome (HIV-AIDS), which since
1960 has resulted in over 35 million deaths, the ongoing cholera since 1961 continued to
cause between 21,000 and 143,000 deaths annually; the 1974 smallpox, which resulted in
over 26,000 deaths; and the 1994 plague that led to roughly 60 deaths (see Bloom and
Cadarette, 2019, Table 1, p. 3).
Additionally, Bloom and Cadarette (2019) indicated that the 2002–2003 severe acute
respiratory syndrome (SARS) caused 774 deaths, the 2009 influenza (Swine flu or H1N1) led to
284,000 deaths, the 2014–2016 Ebola resulted in 11,325 deaths, the ongoing Zika since 2016
caused unknown fatality, the 2017 dengue resulted in 38,000 deaths and the 2017 plague
caused 209 deaths [1]. According to the Coronavirus Resource Center at John Hopkins
University and Medicine, the current 2020–2021 COVID-19 pandemic has caused over 4.55
million deaths, worldwide, as of October 10, 2021.
Comparing the fatalities of the epidemics and pandemics that occurred in the last half of
the 20th century with those of first two decades of the 21st century, one can argue that the
WHO became more experienced and proficient in using collaboration and coordination with
the global health-care systems to mitigate the outbreaks of both known and unknown
infectious disease threats. For instance, according to the Division of Global Migration and
Quarantine (see CDC, 2019), the public health risks associated with the Madagascar
pneumonic plague of 2017 led the WHO to request for technical assistance from the Centers
for Disease Control and Prevention (CDC) because of its substantial expertise about how
infectious diseases can spread to other countries through travel or tourism. Given that WHO’s
global partnership engagement is rooted in many years of infectious diseases preventions,
border health protection practices and the lessons learned from the coordinated global
responses to the recent outbreaks of Ebola and Zika epidemics, the massive spreads and
fatalities of the COVID-19 since 2020, which presently exceed the fatalities associated with the
1957–1958 Asian flu and the 1968–1969 Hong Kong flu combined, raise pertinent questions
about the roles political leaders at the national and/or international levels play in mitigating
global infectious disease threats.
This paper contributes to the ongoing debates in academic and political circles about
global infectious disease threats by analyzing the roles that political leaders play at the
federal, state and local government levels in the USA in curtailing the spreads and
fatalities of global infectious diseases under the presidential leaderships of Obama
and Trump. Both presidents experienced global pandemic outbreaks during their tenure,
and the data from the CDC Data Tracker show much less fatalities under Obama in
IJPL Leaders and countries Years Pathogen Origin or location MR Cases (rank) Fatalities
18,2
Obama 2009 H1N1 Worldwide 0.02 60,800,000y 12,469
USA 2014–2016 Ebola West Africa 50.0 4 2
2015–present Zika Americas 0.04 2,382 1
2010–2016 Dengue Worldwide 0.33 5,387 18
Total 0.02 60,807,773 12,490
136 Trumpz 2017 Plague Madagascar NA NA
USA
Total COVID-19 2020–2021 COVID-19 China 1.7 24,482,050 (1)* 407,202*
Background studies
The world has experienced several episodes of global infectious diseases since the deadliest
Spanish flu of 1918. According to Bloom and Cadarette (2019), no other global pandemic has
IJPL approached the magnitude of the Spanish flu of 1918 in terms of fatality over such a short
18,2 period in which there were 500 million recorded cases and fatality ranging between 30 and
100 million deaths. In Bloom and Cadarette’s (2019) viewpoint, “Humanity’s relatively good
fortune with respect to infectious disease can be attributed, in part, to the elaborate global
health system the world has gradually developed as a bulwark against infectious disease
threats, both known and unknown.” In their study, they discussed prominent infectious
disease outbreaks, epidemics and pandemics of the last century. In doing so, they raised
138 several pertinent issues, including the fact that infectious disease threats pose economic and
social risks and that there are a number of complicating and challenging factors when it
comes to managing the risk of infectious diseases.
According to both authors, several ongoing demographic trends point toward an
increased potential for transmission of pathogens. In this regard, Bloom and Cadarette (2019)
identified several factors, such as population growth, especially in developing countries
where there is a rapid growth in urbanization; climate change that could be an important
factor in driving pathogen transmission; human interactions with animal populations, which
can lead to producing pathogen spillovers; civil (political and social) conflicts that can result
in new disease outbreaks or the exacerbation of ongoing outbreaks and globalization, which
enables many diseases with epidemic and pandemic potential to be transmitted domestically
and across countries worldwide.
In addition, Bloom and Cadarette (2019) pointed out some economic and political
challenges that can impede the implementation of measures needed to prepare for and
respond to infectious disease threats. Among some of the political challenges is the lack of a
reliable mechanism for incentivizing international collaboration and coordination in the
development of new biomedical countermeasures wherein manufacturers from high-income
countries could rely on developing countries to provide biological samples needed for
research and development. Towards that end, the authors recommended the formation of a
multi-disciplinary “Global Technical Council on Infectious Disease Threat” to address
emerging global challenges related to infectious diseases and the associated social and
economic risks. This recommendation is premised on the assumption that a newly created
“Global Technical Council on Infectious Disease Threat” would strengthen the global health
systems by improving collaboration and coordination across organizations, such as the
WHO, national CDCs and pharmaceutical manufacturers; fill the knowledge gaps with
respect to infectious disease tracing/surveillance and treatment; provide the needed funding
for research and development, financing models and the social and economic impacts of
potential threats; and make high-level but medical evidence-based recommendations for
managing global risks associated with infectious diseases.
The spreads and fatalities associated with global infectious diseases have also brought
attention to the use of different types of PPE, including the use of face shields, facemasks,
gloves, goggles and glasses, gowns, head covers, respirators and shoe covers. At the forefront
of these PPE is the use of facemasks by the general public to prevent or reduce the
transmissions of respiratory pathogens. In the face of the global COVID-19 pandemic, many
countries mandated the wearing of facemasks in public areas along with social distancing to
prevent further spread and fatality. The ongoing debate is about the efficacy of wearing
facemasks as the preventive measure for the COVID-19 pandemic.
Vainshelboim (2021) documented several experimental studies, which provided the
scientific basis to question the efficacy of using facemasks. Vainshelboim’s (2021) “evolution
of hypothesis” with respect to medical and nonmedical facemasks covered the “breathing
physiology, efficacy of facemasks, physiological and psychological effects of wearing
facemasks, and the long-term health consequences of wearing facemasks.” Vainshelboim
(2021) concluded that wearing facemasks has been demonstrated to have substantial adverse
physiological and psychological effects and that the long-term consequences can cause health
deterioration, the development and progression of chronic diseases and premature death; The COVID-19
therefore, governments, policymakers and health experts or professionals should utilize pandemic in
proper and scientific-based evidence and approach when wearing facemasks is considered
the preventive intervention for public health. Other studies such as Baryck et al. (2020), Konda
the USA
et al. (2020), Salam et al. (2020), Leung et al. (2020), Chu et al. (2020), MacIntyre et al. (2015) and
Fisher et al. (2014) have mixed views regarding the efficacy of wearing facemasks as
prevention for infectious pathogens. Some of these studies do not have sufficient data to
definitively determine whether N95 facemasks are superior to medical masks in protection 139
against transmissible acute respiratory infections.
Other studies such as Parida et al. (2020) acknowledged that the use of different types of
masks based on the risk of exposure should be taken seriously and should therefore be used
judiciously. Furthermore, Parida et al. (2020) pointed out that since this is a novel disease,
everyone should expect the guidelines to change daily and that
one needs to be updated with correct information so that one can protect themselves and their
families from this extreme level of the crisis faced by the world now. The use of facemasks should not
be discouraged as there has been substantial evidence that its use can help reduce the spread of
infection. “Mass masking” along with hand hygiene and social distancing are the only effective
recommended measures to prevent the spread of the disease.
In a study by Chu et al. (2020), they identified 172 observational studies across 16 countries
and six continents, with no randomized controlled trials and 44 relevant comparative studies
in health-care and nonhealth-care settings, and they found out that the transmission of
viruses was lower with physical distancing of one meter or more when compared with a
distance of less than one meter and that protection increased as distance lengthened. They
also concluded that face mask use could result in a large reduction in the risk of infection with
stronger associations with N95 or similar respirators compared to disposable surgical masks
or similar respirators and that eye protection was associated with less infections (see also
Stutt et al., 2020).
In a series of recent studies in International Journal of Public Leadership, Vol. 17, No. 1,
research scholars pointed out that President Trump’s failure to curb COVID-19 pandemic
could be attributed to many factors, such as his display of maladaptive denial and
concomitant power-addiction (Weidner and Nelson (2021)), the defunding of the Office of
Pandemics and Emerging Threats, and the lack of coordination (Schismenos et al. (2021)),
“deathcare leadership in the USA lacks a human-centric approach” (Entress et al. (2021)) and
the crisis in leaderships at many levels of government as manifested by their inability to
collaborate and coordinate to control the cases and fatalities (Sadiq et al., 2021; Glenn
et al., 2021).
140 SFT ¼ σ PLT $CTT þ μPLT $DIST þ ð–λ þ UÞPLT $CPHRT þ δZ T $CCT $DIST (2)
and
SFAC ¼ – ηPLAC $CCAC – ψ PLAC $CINAC –θPLAC $CPHRAC– π Z AC $CCAC (3)
where SFO represents the spreads and fatalities of H1N1, Ebola, Zika and Dengue under
President Obama, while SFT and SFAC capture the spreads and fatalities of the COVID-19
pandemic under President Trump and the leaders in ten other countries, respectively. Also,
PLO, PLF and PLAC stand for the combination of political leaders at the federal, state/regional
and local levels of government in the USA under Obama and Trump and in other countries,
respectively; CCO, CCT and CCAC capture the magnitude of collaboration and coordination
under the leaders as identified earlier; CPHRO, CPHRT and CPHRAC represent citizens’
perceptions or concerns of the health risks from infectious diseases under the leaders as
identified; CINO and CINAC capture correct information about infectious diseases; CTT and
DIST represent the conspiracy theories and disinformation propagated by political leaders
and ZO, ZT and ZAC represent the catch-all term for the WHO, the CDC and other health-care
systems in the USA and other advanced countries.
Equations (1)–(3) serve to provide the theoretical answers to the questions we posed earlier
in this paper. For example, Equations (1) and (2) enable us to compare how President Obama
handled the spreads and fatalities (SFO) in four different episodes of global infectious diseases
with how President Trump handled the spreads and fatalities (SFT) during the COVID-19
pandemic. Next, Equations (2) and (3) allow us to compare how President Trump handled
SFT relative to how other political leaders in advanced countries handled SFAC during the
COVID-19 pandemic.
To provide a clear interpretation of Equation (1), the partial differentiations of SFO with
respect to the explanatory variables on the right-hand-side yield
vSFO vSFO vPLO
¼ $ ¼ –α; (4)
vCCO vPLO vCCO
vSFO vSFO vPLO
¼ $ ¼ –w; (5)
vCINO vPLO vCINO
vSFO vSFO vPLO
¼ $ ¼ – f; (6)
vCPHRO vPLO vCPHRO
and
vSFO vSFO vZ O
¼ $ ¼ –β: (7)
vZ O vZ O vCCO
The negative “spreads-fatalities curtailment coefficients” (–α; –w; –f and –β) depicted by
these equations show how President Obama used effective collaboration and coordination at all
levels of government in conjunction with scientists, medical experts and professionals at the
WHO, the CDC and other health institutions in the USA to mitigate the spreads and fatalities
associated with H1N1, Ebola, Zika and Dengue during his two-term tenure as the 44th POTUS.
The coefficient (–w) of Equation (5) is particularly important because it shows the degree The COVID-19
to which correct information (see Parida et al., 2020) provided by political leaders can help pandemic in
curtail the spreads and fatalities linked to global infectious diseases. For instance, when
Americans were afraid and distrustful of the resources devoted to curtailing Ebola,
the USA
President Obama came out to allay the fears of the public by delivering a strong statement
in acknowledgment that “People were understandably afraid. And, if we’re honest, some
stoked those fears. But we believed that if we made policy based not on fear, but sound
science and good judgment, America could lead an effective global response while keeping 141
America people safe, and we could turn the tide of the epidemic” (see Condon, 2015). This
was intended not only to reassure the nation of his handling of the Ebola epidemic but also
to build national unity in the fight against Ebola. Furthermore, Equation (6) shows that
when political leaders (especially the POTUS, state governors and city mayors) share the
same perceptions with citizens or show some level of compassion and understanding when
citizens show trepidations about the health risks linked to the spreads and fatalities due to
infectious diseases, the citizens will view the health risks from the same lens and not from
two different lenses.
Similarly, the partial differentiations of SFT in Equation (2) with respect to the explanatory
variables on the right-hand-side yield
and
vSFT vSFT vZ T vCCT
¼ $ $ ¼ π: (11)
vZ T vZ T vCCT vDIST
and
vSFAC vSFAC vZAC
¼ $ ¼ –π : (15)
vZ AC vZ AC vCCAC
and
ST FT
SR ¼ vs FR ¼ ; (18)
SO FO
where ASO and AFO, and AST and ASF are the average annual spreads and fatalities under
Obama and Trump, respectively, while SR and FR are the spread and fatality ratios for
comparing Obama to Trump and also for comparing Trump with leaders in other countries The COVID-19
identified in this study. pandemic in
To show the importance of Equations (16)–(18), we utilized the available data provided by
Worldometer, the CDC Data Tracker and the John Hopkins University up to January 20, 2021
the USA
(the last day Trump’s presidency) to provide comparative quantifications of the average
annual spreads and fatalities under both presidents. The computations of AST, AFT, ASO and
AFO showed that the average annual spread (AST ¼ 6,120,512) and fatality (AFT ¼ 101,800)
under President Trump were remarkably much higher than the average annual spread (ASO 143
¼ 35,260) and fatality (AFO ¼ 1,561) under President Obama. The computed spread ratio (SR)
of 1:2.5 showed that Obama had 2.5 times more cases than Trump. In contrast, the fatality
ratio (FR) of 33:1 showed that Trump had 33 times more fatalities due to the COVID-19
pandemic when compared to Obama’s handling of four different epidemics and pandemics in
eight years.
Notes
1. Bloom and Cadarette (2019) provided detail explanations regarding the pathogen, geographical
locations, and the cases and mortalities of the prominent outbreaks of epidemics and pandemics
since the Spanish flu of 1918–1920.
2. For more on the theories of self-projections and self-deception, see Gur et al. (1979) and Mele (1998).
3. For more on Obama’s actions, see the “Public Papers of the President of the United States,” AE
2.114.2009/Bk.1.
4. Based on the population data obtained on November 16, 2021 from Worldometer and the data on
fatalities obtained from John Hopkins University, the new calculation showed that 1 in every 425
Americans has died due to COVID-19 pandemic.
References
Barycka, K., Szarpak, L., Filipiak, K.J., Jaguszewski, M., Smereka, J., Robert Ladny, J. and Oguz, T.
(2020), “Comparative effectiveness of N95 respirators and surgical/face masks in preventing
airborne infections in the era of SARS-COV2 pandemic: a meta-analysis of randomized trials,”
Vol. 15 No. 12.
Bloom, D.E. and Cadarette, D. (2019), “Infectious disease threats in the twenty-first century:
strengthening the global response”, Frontier in Immunology, Vol. 10, 549.
Bor, J., Himmelstein, D.U. and Woolhandler, S. (2021), “Trump’s policy failures have exacted a heavy
toll on public health”, Scientific American, available at: https://www.scientificamerican.com/
article/trumps-policy-failures-have-exacted-a-heavy-toll-on-public-health1/?amp5true.
Centers for Disease Control and Prevention (2019), “Keeping the Madagascar plague outbreak from
spreading through international points of entry”, available at: https://www.cdc.gov/ncezid/
dgmq/feature-stories/Madagascar-plague.html.
unemann, H.J. (2020), “Physical distancing,
Chu, D.K., Akl, E.A., Duda, S., Solo, K., Yaacoub, S. and Sch€
face masks, and eye protection to prevent Person-to-Person transmission of SARS-CoV-2 and
COVID-19: a systematic review and meta-analysis”, Lancet, Vol. 395, pp. 1973-1987.
Comms, E. (2020), “An embattled landscape series, Part 2a: coronavirus and the three-year Trump
quest to slash science at the CDC”, available at: https://www.washingtonpost.com/news/to-your-
health/wp/2018/05/10/top-white-house-official-in-charge-of-pandemic-response-exits-abruptly/.
IJPL Condon, G. (2015), “Obama’s Ebola victory lap”, National Journal, available at: https://www.
nationaljournal.com/s/31986/.
18,2
Cooper, H., Shear, M.D. and Grady, D. (2014), “U.S. To commit up to 3,000 troops to fight Ebola in
Africa”, available at: https://www.nytimes.com/2014/09/16/world/africa/obama-to-announce-
expanded-effort-against-ebola.html.
DuBrin, A.J. (2013), Leadership: Research Findings, Practice, and Skills, 7th ed, South-Western Cengage
Learning, Masson OH.
148
Ellenberg, J. (2001), “Growing apart: the mathematical evidence for congress’ growing Polarization”,
available at: www.slate.com/articles/life/do_the_math/2001/12/growing_apart.html.
Entress, R.M., Tyler, J., Zavattaro, S.M. and Sadiq, A.-A. (2021), “The need for innovation in deathcare
leadership”, International Journal of Public Leadership, Vol. 17 No. No. 1, pp. 54-64.
Fisher, E., Noti, J.D., Lindsley, W.G., Blanchere, F.M. and Shaffer, R.E. (2014), “Validation and
application of models to predict facemask influenza contamination in healthcare settings”, Risk
Analysis, Vol. 34 No. 8, pp. 1423-1434.
Frieden, T. (2021), “Which countries have responded best to covid-19?”, available at: https://www.wsj.
com/articles/which-countries-have-responded-best-to-covid-19-11609516800.
Gagaridis, A. (2020), “The danger of disinformation and the rise of ochlocracy”, available at: https://
www.intelligencefusion.co.uk/insights/resources/article/the-danger-of-disinformation-and-the-
rise-of-ochlocracy/.
Glenn, J., Chaumont, C. and Dintrans, P.V. (2021), “Public health leadership in the times of COVID-19: a
comparative case study of three countries”, International Journal of Public Leadership, Vol. 17
No. 1, pp. 81-94.
Gur, R.C. and Sackeim, H.A. (1979), “Self-deception: a concept in search of a Phenomenon”, Journal of
Personality and Social Psychology, Vol. 37 No. 2, pp. 147-169.
Karlawish, J. (2020), “A pandemic plan was in place, Trump abandoned it – and science – in the face of
COVID-19”, available at: https://www.statnews.com/2020/05/17/the-art-of-the-pandemic-how-
donald-trump-walked-the-u-s-into-the-covid-19-era/.
Kates, J., Michaud, J., Wexler, A. and Valentine, A. (2015), “The U.S. Response to Ebola: status of the
FY2015 emergency Ebola appropriation,” December 2015, Issue Brief, The Henry J. Kaiser
Family Foundation, pp. 1-9.
Konda, A., Prakash, A., Moss, G.A., Schmoldt, M., Grant, G.D. and Guha, S. (2020), “Aerosol filtration
efficiency of common fabrics used in respiratory cloth masks”, ACS Nano, Vol. 14, pp. 6339-6347.
Landler, M. (2016), “Obama asks congress for $1.8 billion to combat Zika virus”, available at: https://
www.nytimes.com/2016/02/09/us/politics/obama-congress-funding-combat-zika-virus.html.
Leung, N.H.L., Chu, D.K.W., Shiu, E.Y.C., Chan, K.-H., McDevitt, J.J., Hau1, B.J.P., Yen, H.-L., Li, Y.,
Ip, D.K.M., Peiris, J.S.M., Seto, W.-H., Leung, G.M., Milton, D.K. and Cowling, B.J. (2020),
“Respiratory virus shedding in exhaled breath and efficacy of face masks”, Nature Medicine,
Vol. 26, pp. 676-680.
MacIntyre, C.R., Seale, H., Dung, T.C., Hien, N.T., Nga, P.T., Chughtai, A.A., Rahman, B., Dwyer, D.E.
and Wang, Q. (2015), “A cluster of randomized trial of cloth masks comapred with medical
masks in healthcare workers”, BJM Open, Vol. 5 No. 4, pp. 1-10.
Mallinson, D.J. (2020), “Cooperation and conflict in state and local innovation during COVID-19”, The
American Review of Public Administration, Vol. 50 Nos Issue 6-7, pp. 543-550.
Mele, A.R. (1998), “‘Two Paradoxes of self-deception,’ in Jean-Pierre Dupuy”, Self-Deception and
Paradoxes of Rationality, 74th ed., Center for the Study of Language and Inf (CSLI).
Moss, K. and Kates, J. (2019), “The U.S. Congress and global health: a primer”, The Henry J. Kaiser
Family Foundation, pp. 1-22, available at: https://www.kff.org/global-health-policy/.
Organization of Economic Cooperation and Development (OECD (2021)), “Enhancing public trust in
COVID-19 vaccination: the role of governments”, available at: https://read.oecd-ilibrary.org/
view/?ref51094_1094290-a0n03doefx&title5Enhancing-public-trust-in-COVID-19-vaccination- The COVID-19
The-role-of-governments&_ga52.193940909.1444699505.1633872420-776383630.1633872420.
pandemic in
Parida, S.P., Bhatia, V. and Adrija, R. (2020), “Masks in COVID-19 pandemic: are we doing it right?”,
Journal of Family and Primary Care, Vol. 9 No. 10, pp. 5122-5126.
the USA
Prooijen, J.-W., Douglass, K.M. and Inocencio, C.D. (2018), “Connecting the dots: illusory Pattern
perception predicts belief in conspiracies and the supernatural”, European Journal of Social
Psychology, Vol. 48, pp. 320-335.
149
Sadiq, A.-A., Kapucu, N. and Hu, Q. (2021), “Crisis leadership during COVID-19: the role of governors
in the United States”, International Journal of Public Leadership, Vol. 17 No. 1, pp. 65-80.
Salam, A.P., Rojek, A., Cai, E., Raberahona, M. and Horby, P. (2020), “Death associated with
pneumonic plague”, Emerging Infectious Diseases, Vol. 26 No. 10, pp. 2432-2434.
Schismenos, S., Smith, A.A., Stevens, G.J. and Emmanoulodis, D. (2021), “Failure to lead on COVID-19:
what went wrong with the United States”, International Journal of Public Leadership, Vol. 17
No. 1, pp. 39-53.
Soergel, A. (2020), “States compete in ‘global Jungle’ for personal protective equipment amid
coronavirus”, Best States, US News, available at: https://www.usnews.com/news/best-states/
articles/2020-04-07/states-compete-in-global-jungle-for-personal-protective-equipment-amid-
coronavirus.
Stutt, R.O.J.H., Retkute, R., Bradley, M., Gilligan, C.A. and Colvin, J. (2020), “A modelling framework to
assess the likely effectiveness of facemasks in combination with ‘lock-down’ in managing the
COVID-19 pandemic”.
Sun, L.H. (2018), “Top white House official in charge of pandemic response exits abruptly”, available
at: https://www.washingtonpost.com/news/to-your-health/wp/2018/05/10/top-white-house-
official-in-charge-of-pandemic-response-exits-abruptly/.
Vainshelboim, B. (2021), “Facemasks in the COVID-19 era: a health hypothesis”, Medical Hypotheses,
Elsevier, Vol. 146, pp. 1-5.
Weidner, C.K., II and Nelson, Lisa A.T. (2021), “The role of power-addiction and maladaptive denial in
the US federal COVID-19 response”, International Journal of Public Leadership, Vol. 17 No. 1,
pp. 19-38.
Woodward, B. (2020), Rage, Simon & Schuster, New York, September 15, 2020.
Zamarripa, R. (2020), “5 ways the Trump administration’s policy failure compounded the coronavirus-
induced economic crisis”, Center for American Progress, pp. 1-12, 3 June, available at: https://
americanprogress.org/article/5-ways-trump-administrations-policy-failures-compounded-
coronavirus-induced-economic-crisis/.
Further reading
Centers for Disease Control and Prevention (2011), “CDC Estimates of 2009 H1N1 influenza cases,
Hospitalizations and deaths in the United States, April 2009 – January 16, 2010”, available at:
https://www.cdc.gov/h1n1flu/estimates_2009_h1n1.htm.
Centers for Disease Control and Prevention (2021), “United States COVID cases, death, and laboratory
testing (NAATs) by state, territory, and Jurisdiction”, Retrieved from CDC COVID Data
Tracker.
Rivera, A., Adams, L.E., Sharp, T.M., Lehman, J.A., Waterman, S.H. and Paz-Bailey, G. (2020), “Travel-
associated and locally acquired dengue cases – United States”, Morbidity and Mortality Weekly
Report (MMWR), Department of Health and Human Services/Centers for Disease Control and
Prevention, February 14, 2020, Vol. 69 No. 6, pp. 149-154.
Sharp, T.M., Fischer, M., Munoz Jordan, J., Paz-Bailey, G., Staples, J.E., Gregory, C.J. and William, S.H.
(2019), “Dengue and Zika virus diagnostic testing for Patients with a clinically compatible
illness and risk for infection with both virus”, Morbidity and Mortality Weekly Report (MMWR),
IJPL Department of Health and Human Services/Centers for Disease Control and Prevention, June 14,
2019, Vol. 68 No. 1, pp. 1-10.
18,2
Smith, J.D., MacDougall, C.C., Johnstone, J., Copes, R.A., Schwartz, B. and Garber, G.E. (2016),
“Effectiveness of N95 respirators versus surgical masks in protecting health care workers from
acute respiratory infection: a systematic review and meta-analysis”, CMAJ, Vol. 188,
pp. 567-574.
Walker, W.I., Lindsey, N.P., Lehman, J.A., Krow-Lucal, E.R., Rabe, I.B., Hills, S.I., Martin, S.W.,
150 Fischer, M. and Staples, J.E. (2016), “Zika virus disease cases – 50 states and the District of
Columbia, January 1–July 31, 2016”, Morbidity and Mortality Weekly Report (MMWR),
Department of Health and Human Services/Centers for Disease Control and Prevention,
September 16, 2016, , Vol. 65 No. 36, pp. 983-986.
Corresponding author
Oluwole Owoye can be contacted at: [email protected]
For instructions on how to order reprints of this article, please visit our website:
www.emeraldgrouppublishing.com/licensing/reprints.htm
Or contact us for further details: [email protected]